• Login
• Admin

2018

El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad and Green, Andrew R. (2018) The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours. Breast Cancer Research, 20 (21). pp. 1-17. ISSN 1465-542X

El Ansari, Rokaya, Craze, Madeleine L., Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A. and Green, Andrew R. (2018) The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes. British Journal of Cancer, 118 . pp. 1115-1122. ISSN 1532-1827

2017

Craze, Madeleine L., Cheung, Hayley, Jewa, Natasha, Coimbra, Nuno D.M., Soria, Daniele, El-Ansari, Rokaya, Aleskandarany, Mohammed A., Cheng, Kiu Wai, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad and Green, Andrew R. (2017) MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer. British Journal of Cancer . ISSN 1532-1827

El Ansari, Rokaya, McIntyre, Alan, Craze, Madeleine L., Ellis, Ian O., Rakha, Emad A. and Green, Andrew R. (2017) Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations. Histopathology . ISSN 0309-0167

Chrysanthou, Eleni, Gorringe, Kylie L., Joseph, Chitra, Craze, Madeleine L., Nolan, Christopher C., Diez-Rodriguez, Maria, Green, Andrew R., Rakha, Emad A., Ellis, Ian O. and Mukherjee, Abhik (2017) Phenotypic characterization of breast cancer: the role of CDC42. Breast Cancer Research and Treatment, 164 (2). pp. 317-325. ISSN 1573-7217

Onion, David, Isherwood, Mark, Shridhar, Naveen, Xenophontos, Mikalena, Craze, Madeleine L., Day, Laura J., Gárcia-Marquez, Maria A., Pineda, Robert G., Reece-Smith, Alex M., Saunders, John H., Duffy, John P., Argent, Richard H. and Grabowska, Anna M. (2017) Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer. Oncotarget . ISSN 1949-2553

Joseph, C., Craze, Madeleine L., Nolan, C.C., Diez-Rodriguez, Maria, Green, Andrew R., Rakha, Emad, Ellis, Ian O. and Mukherjee, A. (2017) FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype. In: Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 June 2017, Belfast , United Kingdom.

2016

Onion, David, Argent, Richard H., Reece-Smith, Alex M., Craze, Madeleine L., Pineda, Robert G., Clarke, Philip A., Ratan, Hari L., Parsons, Simon L., Lobo, Dileep N., Duffy, John P., Atherton, John C., McKenzie, Andrew J., Kumari, Rajendra, King, Peter, Hall, Brett M. and Grabowska, Anna M. (2016) 3-dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors. Molecular Cancer Therapeutics, 15 (4). pp. 753-763. ISSN 1538-8514